Vai al contenuto
Dialybrid

Dialybrid

Hybrid arteriovenous graft for hemodialysis

Menu
  • Company
    • History
    • Mission
    • Team
  • Technology
    • Silk fibroin and polyurethane
    • Silkothane®
    • Electrospinning
  • Products
    • Silkothane® Arteriovenous Graft
    • Silkothane® Arteriovenous Graft’s biomimetic nanostructure
    • In situ tissue engineering
  • News
  • Contacts
Dialybrid News Dialybrid Foundation
aggiornato il Novembre 24, 2020Agosto 1, 2020News

Dialybrid Foundation

Avatar Dialybrid

LIFTT, the investment operating company founded by Fondazione Compagnia Di San Paolo and Politecnico di Torino, and Bioengineering Laboratories S.r.l. (“BEL”), a medical device company controlled by the Delta Med group and its founder Francesco Greco, join in a strategic-financialpartnership in the BioMed sector.

https://www.liftt.com/wp-content/uploads/2020/08/LIFTT_focuses_on_Dialybrid_a_new_frontier_in_haemodialysis.pdf

Articolo precedente Silkothane® Graft @ Vas 2019, Rotterdam
Articolo successivo Dialybrid @ VAS 2023, Porto

Articoli consigliati

aggiornato il Settembre 22, 2026Settembre 22, 2026News

Dialybrid @ LSI Europe ’26 Emerging MedTech Summit, BARCELONA

aggiornato il Settembre 21, 2026Maggio 10, 2026News

Dialybrid @ San Giovanni Rotondo

aggiornato il Settembre 22, 2026Settembre 22, 2026News

Dialybrid announces successful first-in-human implant of Silkothane® Arteriovenous Graft for vascular access in hemodialysis

Dialybrid S.r.l.

Headquarter &
Registered Office

Via Antonio Vivaldi 32/A,
22063 Cantù (CO)
Italy

Contacts

Tel. +39 031 7377739
Mail: info@dialybrid.com

Privacy Policy
Cookie Policy

INFORMATION

Reg. Imprese COMO LECCO
VAT n. 11357080966
Shared Capital € 451.166,00 fully paid in

Vilva | Sviluppato da Blossom Themes. Powered by WordPress.